Top

Published in:

Open Access 01-11-2013 | Meeting abstract

P02-027 - Quality of life in CAPS treated by Canakinumab

Authors: C Marsaud, I Marie, I Koné-Paut

Published in: Pediatric Rheumatology | Special Issue 1/2013

Excerpt

The impact of cryopyrin associated periodic syndrome (CAPS) on quality of life (QoL) is very high. Constitutional symptoms, extreme fatigue, chronic pain and physical limitation lead to severe restriction of daily activities and social life. In addition neurological and sensory impairments may aggravate social exclusion of these patients. …

Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P: Use of canakinumab in the cryopyrin-associated periodic syndrome. N. Engl. J. Med. 2009, 360 (23): 2416-25. 10.1056/NEJMoa0810787.CrossRefPubMed

Title: P02-027 - Quality of life in CAPS treated by Canakinumab
Authors: C Marsaud
I Marie
I Koné-Paut
Publication date: 01-11-2013
Publisher: BioMed Central
Published in: Pediatric Rheumatology / Issue Special Issue 1/2013
Electronic ISSN: 1546-0096
DOI: https://doi.org/10.1186/1546-0096-11-S1-A134

At a glance: The STEP trials

Springer Medicine

P02-027 - Quality of life in CAPS treated by Canakinumab

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2013

PW03-016 – Blau prospective cohort study: articular outcomes

PW02-008 - TRAPS in the real world: an international registry

PW02-006 - PAPA syndrome clinical spectrum and IL1B release

PW02-010 - The diagnostic challenge of bone lesions in AID

PW01-014 – MEFV methylation analysis in FMF and JRA diseases

P03-028 – Spectacular efficiency of isotretinoin in small doses in the sebopsoriasis treatment